The Drug Development Process
There are five steps in the drug development process, which are designed to help ensure that potential new therapies are both safe and effective. The Rare Disease Cures AcceleratorData and Analytics Platform (RDCADAP), which NORD and the Critical Path Institute (CPath) are developing, will aid in these steps and help contribute to faster development of medications for rare diseases, 90 of which are still without an FDAapproved treatment. Together, NORD and CPath have created a threepart video series, Accelerating Rare Disease Drug This is the first video in the series, addressing the basics of the drug development process. Learn more:
|
|